According to BlockBeats, iSpecimen Inc., a biosample procurement company, is currently assessing investment proposals from several cryptocurrency firms to advance its $200 million crypto treasury initiative. The company is simultaneously progressing with a treasury project based on SOL, intending to purchase SOL through over-the-counter transactions, including acquiring locked SOL with transfer restrictions.
Robert Lim, CEO of iSpecimen Inc., noted that while acquiring locked SOL is appealing, the company is still exploring other opportunities. iSpecimen plans to adopt a buy-and-hold strategy to fund its crypto treasury through regular fundraising efforts and intends to stake SOL to generate returns.
